Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum -lactamases, AmpC -lactamases and reduced susceptibility to carbapenems using an in vitro model
Zhanel, G. G., Baudry, P. J., Tailor, F., Cox, L., Hoban, D. J., Karlowsky, J. A.Volume:
64
Language:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dkp254
Date:
October, 2009
File:
PDF, 98 KB
english, 2009